18
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Melanoma Antigen Genes 1 and 2 Are Differentially Expressed in Human Gastric and Cardial Carcinomas

Pages 528-533 | Published online: 08 Jul 2009

References

  • References
  • De Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora JP, de Smet C, et al. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 1994;40: 360–9.
  • Rogner UC, Wilke K, Steck E, Korn B, Ponstka A. The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28. Genomics 1995;29: 725–31.
  • Van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van der Eynde B, et al. A gene encoding an antigen recognized by cytolytic T-lymphocytes on a human melanoma. Science 1991;254:1643–7.
  • Corrias MV, Scaruffi P, Occhino M, de Bernardi B, Tonini GP, Pistoia V. Expression of MAGE-1, MAGE-3 and MART-1 genes in neuroblastoma. Int J Cancer 1996;69: 403–7.
  • Inoue H, Mori M, Honda M, Li J, Shibuta K, Mimori K, et al. The expression of tumor-rejection antigen ‘MAGE’ genes in human gastric carcinoma. Gastroenterology 1995;109:1522–5.
  • Katano M, Nakamura M, Morisaki T, Fujimoto K. Melanoma antigen-encoding gene-1 expression in invasive gastric carcinoma: correlation with stage of disease. J Surg Oncol 1997;64: 195–201.
  • Li J, Yang Y, Fujie T, Tanaka F, Mimori K, Haraguchi M, et al. Expression of the MAGE gene family in human gastric carcinoma. Anticancer Res 1997;17(5a):3559–63.
  • Quillien V, Raoul JL, Heresback D, Collet B, Tonjas L, Brasseur F. Expression of MAGE genes in esophageal squamous-cell carcinoma. Anticancer Res 1997;17:387–91.
  • Toh Y, Yamana H, Shichijo S, Fujita H, Tou U, Minako S, et al. Expression of MAGE-1 gene by esophageal carcinomas. Jpn J Cancer Res 1995;86:714–7.
  • Yamada A, Kataoka A, Shichijo S, Kamura T, Imai Y, Nishida T, Itoh K. Expression of MAGE-1, MAGE-2, MAGE-3/-6 and MAGE-4a/-4b genes in ovarian tumors. Int J Cancer 1995;64: 388–93.
  • Fujie T, Mori M, Ueo H, Sugimachi K, Akiyoshi T. Expression of MAGE and BAGE genes in Japanese breast cancers. Ann Oncol 1997;8:369–72.
  • Toso JF, Oei C, Oshidari F, Tartaglia J, Paoletti E, Lyerly HK, et al. MAGE-1-specific precursor cytotoxic T lymphocytes present among tumor-infiltrating lymphocytes from a patient with breast cancer: characterization and antigen-specific activation. Cancer Res 1996;65:16–20.
  • Mori M, Inoue H, Mimori K, Shibuta K, Baba K, Nakashima H, et al. Expression of MAGE genes in human colorectal carcinoma. Ann Surg 1996;224:183–8.
  • Patard JJ, Brasseur F, Gil-Diez S, Radvanyi F, Marchand M, Francois P, et al. Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder. Int J Cancer 1995;64:60–4.
  • Zakut R, Topalian SL, Kawakami Y, Mancini M, Eliyahu S, Rosenberg SA. Differential expression of MAGE-1, -2 and -3 messenger RNA in transformed and normal human cell lines. Cancer Res 1993;53:5–8.
  • Itoh K, Hayashi A, Nakao M, Hoshino T, Seki N, Shichijo S. Human tumor rejection antigens MAGE. J Biochem 1996;119: 385–90.
  • Becker JC, Gillitzer R, Brocker EB. A member of the melanoma antigen-encoding gene (MAGE) family is expressed in human skin during wound healing. Int J Cancer 1994;58:346–8.
  • Inoue H, Li J, Honda M, Nakashima R, Shibuta K, Arinaga S, et al. MAGE-1 mRNA expression in gastric carcinoma [letter]. Int J Cancer 1995;64:76–7.
  • Inoue H, Mori M, Li J, Mimori K, Honda M, Nakashima H, et al. Human esophageal carcinomas frequently express the tumor-rejection antigens of MAGE genes. Int J Cancer 1995;63:523–6.
  • Weber J, Salgeller M, Samid D, Johnson B, Herljn M, Lassam N, et al. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2′-deoxycytidine. Cancer Res 1994;54:1766–71.
  • Montesano R, Hollstein M, Hainaut P. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer 1996;69:225–35.
  • Bogomoletz WY. The pathology of adenocarcinoma of the cardia. In: Peracchia A, Rosati R, Bonavina L, Fumagalli U, Bona S, Chella B, editors. Recent advances in diseases of the esophagus. Bologna: Monduzzi Ed.; 1996. p. 557–60.
  • Holscher AH, Bollschweiler E, Siewert JR. Carcinoma of the gastric cardia. Ann Chir Gynaecol 1995;84:185–92.
  • Powell J, Mc Conkey CC. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer 1990;62:440–3.
  • Ruol A, Merigliano S, Baldan N, Santi S, Petrin GF, Bonavina L, et al. Prevalence, management and outcome of early adenocarcinoma (pT1) of the esophago-gastric junction. Comparison between early cancer in Barrett’s esophagus (type I) and early cancer of the cardia (type II). Dis Esophagus 1997;10: 190–5.
  • Van Dekken H, Geelen E, Dinjens WNM, Wijnhoven BPL, Tilanus HW, Tanke HJ, et al. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14q31–32.1 discriminates between esophageal (Barrett’s) and gastric cardia adenocarcinomas. Cancer Res 1999;59:748–52.
  • Hansen S, Melby KK, Aase S, Jellum E, Vollset SE. Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer. Scand J Gastroenterol 1999;34:353–60.
  • Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. Am J Surg Pathol 1996;20:1161–81.
  • Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156–9.
  • Correa P. A human model of gastric carcinogenesis. Cancer Res 1988;48:3554–60.
  • Rokkas T, Filipe MI, Sladen GE. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. Gut 1991;32: 1110–3.
  • Hoon DSB, Yuzuki D, Hayashida M, Morton DL. Melanoma patients immunized with melanoma cell vaccine induce antibody responses to recombinant MAGE-1 antigen. J Immunol 1995;154:730–7.
  • Lucas S, de Smet C, Arden KC, Viars CS, Lethe B, Lurquin C, et al. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res 1998;58:743–52.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.